Project Blueprint

Project Blueprint is bryan johnson’s longevity protocol and commercial health platform. It began as an N=1 self-experiment: measure organ systems and biomarkers, choose interventions from literature and clinical practice, implement them with a medical team, then re-measure. Johnson’s 2021 framing was explicitly system-oriented: his body would generate the “grocery shopping list,” and the core innovation was a feedback loop where organs and biomarkers outranked momentary preference.

By 2026, Blueprint had expanded into a public “Protocol Marketplace,” supplements/foods/skincare, certified products, biomarker testing, an AI health companion, and user-facing protocol personalization. The biomarker page advertises urine and blood testing, 100+ biomarkers, 160+ measurements per year, past-lab import, six-month retesting, and AI-generated evidence-backed protocol guidance.

Methodology

The methodology is a closed-loop optimization system:

  1. Define a health/longevity target, often in terms of biological age, organ age, or speed of aging.
  2. Measure extensively: blood/urine biomarkers, imaging, functional tests, wearable data, and epigenetic clocks.
  3. Choose interventions using scientific literature, clinical practice, and self-experimentation.
  4. Run the protocol with discipline: diet, sleep, exercise, supplements, prescriptions, devices, imaging, and occasional experimental therapies.
  5. Re-measure, drop failures, iterate.

This makes Blueprint a concrete example of biomarker driven longevity protocols: the decision system is the product, not just any one food, supplement, or device.

Claimed benefits and accessible core

Johnson’s protocol materials emphasize simple, repeatable behaviors as well as expensive testing: lower resting heart rate before bed, keep a consistent bedtime, stop food several hours before sleep, avoid evening screens, exercise, and measure progress. His X/Twitter posts in May 2026 repeatedly returned to sleep timing, RHR, sauna, vaccines, peptides, and the idea that “biomarkers in context” are more useful than raw measurement.

Commercialization

Blueprint has become a product ecosystem. Its site offers protocols and products by benefit area (daily health/longevity, brain/heart, energy/stress, muscle/recovery, nutrition, gut/immune, hair/skin), and claims its products are built on population-level studies, tested, and certified. Biomarkers membership is positioned as a lower-cost way to bring Johnson’s “scientific framework” to users.

Limits and critiques

The core scientific limitation is N=1: Johnson changed many variables simultaneously, with no control group, making causal attribution impossible. YEARS emphasizes that data volume and clinical relevance are different; epigenetic clocks are predictors, not proof that a lower score adds healthy years. MDLinx similarly notes that some elements (sleep, exercise, some monitoring) have support, while other aspects — 100+ supplements, extensive imaging, off-label/experimental interventions — may not be generalizable or necessary.

The practical takeaway is to separate Blueprint into layers: evidence-backed basics (sleep, exercise, nutrition, clinically indicated testing), data-driven personalization, commercial products, and experimental/medical interventions. The first two are broadly useful concepts; the latter two require stronger skepticism, medical supervision, and conflict-of-interest awareness.